Literature DB >> 18588874

Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions.

Akari Kato1, Toshiya Endo, Shun Abiko, Hiroyoshi Ariga, Ken-ichi Matsumoto.   

Abstract

XB-S is an amino-terminal truncated protein of tenascin-X (TNX) in humans. The levels of the XB-S transcript, but not those of TNX transcripts, were increased upon hypoxia. We identified a critical hypoxia-responsive element (HRE) localized to a GT-rich element positioned from -1410 to -1368 in the XB-S promoter. Using an electrophoretic mobility shift assay (EMSA), we found that the HRE forms a DNA-protein complex with Sp1 and that GG positioned in -1379 and -1378 is essential for the binding of the nuclear complex. Transfection experiments in SL2 cells, an Sp1-deficient model system, with an Sp1 expression vector demonstrated that the region from -1380 to -1371, an HRE, is sufficient for efficient activation of the XB-S promoter upon hypoxia. The EMSA and a chromatin immunoprecipitation (ChIP) assay showed that Sp1 together with the transcriptional repressor histone deacetylase 1 (HDAC1) binds to the HRE of the XB-S promoter under normoxia and that hypoxia causes dissociation of HDAC1 from the Sp1/HDAC1 complex. The HRE promoter activity was induced in the presence of a histone deacetylase inhibitor, trichostatin A, even under normoxia. Our results indicate that the hypoxia-induced activation of the XB-S promoter is regulated through dissociation of HDAC1 from an Sp1-binding HRE site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588874     DOI: 10.1016/j.yexcr.2008.05.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

Review 1.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

2.  HEXIM1 down-regulates hypoxia-inducible factor-1α protein stability.

Authors:  I-Ju Yeh; Ndiya Ogba; Heather Bensigner; Scott M Welford; Monica M Montano
Journal:  Biochem J       Date:  2013-12-01       Impact factor: 3.857

3.  Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations.

Authors:  Kapil Saxena; Kathryn J Kitzmiller; Yee Ling Wu; Bi Zhou; Nazreen Esack; Leena Hiremath; Erwin K Chung; Yan Yang; C Yung Yu
Journal:  Mol Immunol       Date:  2009-01-09       Impact factor: 4.407

4.  Nerve growth factor-mediated regulation of low density lipoprotein receptor-related protein promoter activation.

Authors:  Tomas R Grana; Jonathan LaMarre; Bettina E Kalisch
Journal:  Cell Mol Neurobiol       Date:  2012-11-29       Impact factor: 5.046

Review 5.  Transcriptional regulation of tenascin genes.

Authors:  Francesca Chiovaro; Ruth Chiquet-Ehrismann; Matthias Chiquet
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

6.  Tenascin-X-Discovery and Early Research.

Authors:  Walter L Miller
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

Review 7.  Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Cancers (Basel)       Date:  2015-12-23       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.